Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Alexander

Showing results (101-110 of 124) with videos related to

Pageof 13
Sort By:
Acta Cirurgica Brasileira|October 21, 2020
Macro and microscopic comparison of the upper pole of the spleen with the lower pole in partial splenectomyLucas Nagib Lemos Paulo, Daniel Robert Alexander, Elisa Ines Demuner Vallandro, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 16, 2025
Donanemab in preclinical Alzheimer's disease: Screening and baseline data from TRAILBLAZER-ALZ 3Roy Yaari, Karen C Holdridge, Melissa Williamson, et al.
Frontiers in Medicine|March 8, 2024
Physical and respiratory therapy in the critically ill patient with obesity: a narrative reviewMiguel Ángel Martínez-Camacho, Robert Alexander Jones-Baro, Alberto Gómez-González, et al.
Nature Communications|April 25, 2024
Ambient carbon dioxide concentration correlates with SARS-CoV-2 aerostability and infection riskAllen Haddrell, Henry Oswin, Mara Otero-Fernandez, et al.
Journal of the Royal Society, Interface|June 21, 2023
Differences in airborne stability of SARS-CoV-2 variants of concern is impacted by alkalinity of surrogates of respiratory aerosolAllen Haddrell, Mara Otero-Fernandez, Henry Oswin, et al.
Journal of Sleep Research|March 19, 2023
Orexin 2 receptor-selective agonist danavorexton (TAK-925) promotes wakefulness in non-human primates and healthy individualsRebecca Evans, Haruhide Kimura, Masato Nakashima, et al.
Clinical Pharmacology in Drug Development|April 30, 2016
Population pharmacokinetic and pharmacodynamic analysis of plasma Aβ40 and Aβ42 following single oral doses of the BACE1 inhibitor AZD3839 to healthy volunteersAngelica Quartino, Gunilla Huledal, Erik Sparve, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 22, 2022
Orexin 2 receptor-selective agonist danavorexton improves narcolepsy phenotype in a mouse model and in human patientsRebecca Evans, Haruhide Kimura, Robert Alexander, et al.
Acute and Critical Care|February 2, 2024
Prolonged intensive care: muscular functional, and nutritional insights from the COVID-19 pandemicMiguel Ángel Martínez-Camacho, Robert Alexander Jones-Baro, Alberto Gómez-González, et al.
Journal of Psychopharmacology (Oxford, England)|March 30, 2013
Full central neurokinin-1 receptor blockade is required for efficacy in depression: evidence from orvepitant clinical studiesEmiliangelo Ratti, Paolo Bettica, Robert Alexander, et al.
Pageof 13

Showing results (101-110 of 124) with videos related to

Sort By:
Pageof 13
Acta Cirurgica Brasileira|October 21, 2020
Macro and microscopic comparison of the upper pole of the spleen with the lower pole in partial splenectomyLucas Nagib Lemos Paulo, Daniel Robert Alexander, Elisa Ines Demuner Vallandro, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 16, 2025
Donanemab in preclinical Alzheimer's disease: Screening and baseline data from TRAILBLAZER-ALZ 3Roy Yaari, Karen C Holdridge, Melissa Williamson, et al.
Frontiers in Medicine|March 8, 2024
Physical and respiratory therapy in the critically ill patient with obesity: a narrative reviewMiguel Ángel Martínez-Camacho, Robert Alexander Jones-Baro, Alberto Gómez-González, et al.
Nature Communications|April 25, 2024
Ambient carbon dioxide concentration correlates with SARS-CoV-2 aerostability and infection riskAllen Haddrell, Henry Oswin, Mara Otero-Fernandez, et al.
Journal of the Royal Society, Interface|June 21, 2023
Differences in airborne stability of SARS-CoV-2 variants of concern is impacted by alkalinity of surrogates of respiratory aerosolAllen Haddrell, Mara Otero-Fernandez, Henry Oswin, et al.
Journal of Sleep Research|March 19, 2023
Orexin 2 receptor-selective agonist danavorexton (TAK-925) promotes wakefulness in non-human primates and healthy individualsRebecca Evans, Haruhide Kimura, Masato Nakashima, et al.
Clinical Pharmacology in Drug Development|April 30, 2016
Population pharmacokinetic and pharmacodynamic analysis of plasma Aβ40 and Aβ42 following single oral doses of the BACE1 inhibitor AZD3839 to healthy volunteersAngelica Quartino, Gunilla Huledal, Erik Sparve, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 22, 2022
Orexin 2 receptor-selective agonist danavorexton improves narcolepsy phenotype in a mouse model and in human patientsRebecca Evans, Haruhide Kimura, Robert Alexander, et al.
Acute and Critical Care|February 2, 2024
Prolonged intensive care: muscular functional, and nutritional insights from the COVID-19 pandemicMiguel Ángel Martínez-Camacho, Robert Alexander Jones-Baro, Alberto Gómez-González, et al.
Journal of Psychopharmacology (Oxford, England)|March 30, 2013
Full central neurokinin-1 receptor blockade is required for efficacy in depression: evidence from orvepitant clinical studiesEmiliangelo Ratti, Paolo Bettica, Robert Alexander, et al.
Pageof 13